Kinex Pharmaceuticals, a specialty biotech focused on the development and commercialization of next generation oral therapies for cancer diseases, has appointed Flint D. Besecker to its executive team as chief financial officer and executive vice president. Besecker will have primary responsibility over all non-scientific aspects of Kinex, reporting to Kinex's chief executive officer, Dr. Johnson Lau. Flint has been an investor and board director of Kinex since 2011.
"Flint has experience in capital markets and strategy having worked for GE Healthcare Financial Services and as founder and president of CIT Healthcare; both fortune 500 companies. He also has experience in a public company environment having led Care Investment Trust's initial public offering and listing on the New York Stock Exchange," Lau said.
Besecker has 20 years of experience in the healthcare industry. He currently runs Firestone Asset Management, a private investment and advisory firm in the healthcare industry. He also is vice chairman of Ameris Acquisitions, a private Nashville hospital company. His previous roles included chief executive officer of the Center for Hospice and Palliative Care, founder of Care Investment Trust, founder of CIT Healthcare, managing director of GE Healthcare Financial Services and chief risk officer of Heller Healthcare.